Allergan's possible last call for Inamed shares as FTC (Federal Trade Commission) decision on merger imminent
This article was originally published in Clinica
Executive Summary
Allergan could be just days away from closing its acquisition of breast implant maker Inamed, as the US Federal Trade Commission (FTC) is expected to reach a decision on the proposed transaction by the end of this week.